Peptide drugs, once limited to naturally derived compounds, have undergone a transformative journey through advancements in synthetic chemistry and analytical techniques. Despite initial challenges in terms of stability, delivery, and competition from small molecule drugs, the field has witnessed a resurgence fueled by the success of GLP-1-based therapies.

This review provides an overview of the evolution of peptide drugs, emphasizing the complexities of their development and manufacturing. It highlights the critical role of analytical services in addressing these challenges and ensuring the successful translation of peptide-based innovations into life-changing medicines.

Company:

View Solvias USA, Inc.'s profile

Links:

https://info.solvias.com/peptides-white-paper